Clinical trial

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT03478683

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-06-25

PhasePHASE4

Study timeline

Study start (actual)2018-06-25Date precision: day

Registry last updated2020-10-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

budesonide/formoterolDRUG

albuterol/salbutamolDRUG

Placebo to match budesonide/formoterolDRUG

tiotropiumDRUG · verified · RxNorm: tiotropium

Placebo to match FF/UMEC/VIDRUG

placebo to match tiotropiumDRUG

MDIDEVICE

HandiHalerDEVICE

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

MiamiFlorida, United States4 ColumbusOhio, United States2 ClearwaterFlorida, United States2 OcalaFlorida, United States2 HoustonTexas, United States1 PortlandOregon, United States1 BerlinGermany1 The BronxNew York, United States1 HamburgGermany1 AlbuquerqueNew Mexico, United States1 GreenvilleSouth Carolina, United States1 RaleighNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03478683 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.